Verismo Therapeutics’ Initial Clinical Data from STAR-101 Phase 1 Trial of SynKIR™-110 KIR-CAR Presented at AACR 2026 Plenary Session

B Early clinical data show a favorable safety profile and dose-dependent efficacy signals across initial dose level cohorts 1 – 3 in advanced solid tumors for…
posteditor
posteditor
Articles: 17424

Other News